|
Transcripts that showed significantly increased expression in ogt-1(ok1474) neuronal cells isolated by FACs comparing to in FACs isolated neuronal cells from wild type. |
DESeq2, fold change > 2, FDR < 0.05. |
WBPaper00066485:ogt-1(ok1474)_upregulated_neuron
|
|
Transcripts that showed significantly decreased expression in day 3 adult hermaphrodite comparing to in L4 larva glp-1(e2141) animals. |
Fold change > 2, FDR < 0.05 |
WBPaper00064088:Day-3-adult_vs_L4_downregulated_glp-1(e2141)
|
|
Transcripts that showed significantly decreased expression in lipl-4 overexpression transgenic lines comparing to wild type control animals. |
DESeq2 fold change > 2, FDR < 0.05. |
WBPaper00064156:lipl-4(overexpress)_downregulated
|
Bacteria infection: Enterococcus faecalis OG1RF. 16 hours of exposure after L4 larva stage at 25C. |
Transcripts that showed significantly decreased expression in N2 animals fed by E. faecalis strain OG1RF for 16 hours after L4 larva stage at 25C. |
DESeq2, fold change > 2. |
WBPaper00061081:E.faecalis_downregulated_N2
|
Bacteria infection: Enterococcus faecalis OG1RF. 16 hours of exposure after L4 larva stage at 25C. |
Transcripts that showed significantly decreased expression in skpo-1(ok1640) animals fed by E. faecalis strain OG1RF for 16 hours after L4 larva stage at 25C. |
DESeq2, fold change > 2. |
WBPaper00061081:E.faecalis_downregulated_skpo-1(ok1640)
|
|
Transcripts that showed significantly decreased expression in N2 day 3 adults comparing to in N2 day 1 adult animals according to Illumina RNASeq. |
DESeq fold change > 2, FDR < 0.05. |
WBPaper00067499:Day3_vs_Day1_downregulated_Illumina
|
|
Transcripts that showed significantly decreased expression in N2 day 4 adults comparing to in N2 day 1 adult animals according to Illumina RNASeq. |
DESeq fold change > 2, FDR < 0.05. |
WBPaper00067499:Day4_vs_Day1_downregulated_Illumina
|
|
Transcripts that showed significantly decreased expression in N2 day 5 adults comparing to in N2 day 1 adult animals according to Illumina RNASeq. |
DESeq fold change > 2, FDR < 0.05. |
WBPaper00067499:Day5_vs_Day1_downregulated_Illumina
|
|
Transcripts that showed significantly decreased expression in N2 day 7 adults comparing to in N2 day 1 adult animals according to Illumina RNASeq. |
DESeq fold change > 2, FDR < 0.05. |
WBPaper00067499:Day7_vs_Day1_downregulated_Illumina
|
|
Transcripts that showed significantly decreased expression in N2 day 10 adults comparing to in N2 day 1 adult animals according to Illumina RNASeq. |
DESeq fold change > 2, FDR < 0.05. |
WBPaper00067499:Day10_vs_Day1_downregulated_Illumina
|
|
Transcripts that showed significantly decreased expression in N2 day 15 adults comparing to in N2 day 1 adult animals according to Illumina RNASeq. |
DESeq fold change > 2, FDR < 0.05. |
WBPaper00067499:Day15_vs_Day1_downregulated_Illumina
|
|
Transcripts that showed significantly decreased expression in dhgd-1(tm6671) comparing to in N2 animals. |
DESeq2 v3.6.3. Fold change > 2, FDR < 0.05. |
WBPaper00065272:dhgd-1(tm6671)_downregulated
|
|
Transcripts that showed significantly increased expression in hda-2(ok1479) comparing to in N2 animals. |
DESeq2 (version 1.28.1), FDR < 0.01, fold change > 2. |
WBPaper00062159:hda-2(ok1479)_upregulated
|
|
Transcripts that showed significantly increased expression in ilc-17.1(syb5296) comparing to in N2 animals at L4 larva stage. |
DESeq2, fold change > 2, FDR < 0.05. |
WBPaper00066594:ilc-17.1(syb5296)_upregulated
|
|
Transcripts that showed significantly increased expression in npr-15(tm12539) comparing to in N2 at L4 larva stage. |
Fold change > 2, FDR < 0.05. |
WBPaper00066608:npr-15(tm12539)_upregulated
|
Bacteria ibfection: Pseudomonas aeruginosa PA14 |
Transcripts that showed significantly decreased expression in N2 animals exposed to PA14, comparing to in N2 animals grown on OP50. |
fold change > 2, FDR < 0.05 |
WBPaper00066858:PA14_downregulated_N2
|
Bacteria ibfection: Pseudomonas aeruginosa PA14 |
Transcripts that showed significantly decreased expression in osm-3(p802) animals exposed to PA14, comparing to in osm-3(p802) animals grown on OP50. |
fold change > 2, FDR < 0.05 |
WBPaper00066858:PA14_downregulated_osm-3(p802)
|
|
Transcripts that showed significantly decreased expression in eat-2(ad465);dve-1(RNAi) animals comparing to eat-2(ad465) animals injected with empty vector. |
fold change > 2, FDR < 0.01 |
WBPaper00067391:dve-1(RNAi)_downregulated_eat-2(ad465)
|
|
Transcripts that showed significantly increased expression in him-17(me24) comparing to in N2 animals. |
DESeq2, fold change > 2, FDR < 0.05. |
WBPaper00064769:him-17(me24)_upregulated
|
Acidic Environment: PH 4.33 vs. PH 6.33. |
Transcripts that showed significantly increased expression after 3 hours of exposure to acidic environment (PH 4.33), comparing to control animals exposed to PH 6.33 environment. |
DESeq2 (1.16.1). The Benjamini and Hochberg's approach was used to adjust the resulting P-values to control the false discovery rate. Corrected value of P < 0.05 and fold change > 2 were set as the threshold for significantly differential expression. |
WBPaper00060434:pH4.33_vs_pH6.33_uprgulated
|
|
Transcripts that showed significantly increased expression in plp-1(ok2155) adult animals comparing to in wild type. |
DESeq2. Genes with at least 2-fold upregulation with a raw P value <= 0.05 only are listed. |
WBPaper00060526:plp-1(ok2155)_upregulated
|
Bacteria infection: Staphylococcus aureus |
Transcripts that showed significantly increased expression in animals experimentally colonised by a wild microbiota community and infected by the widespread animal pathogen, Staphylococcus aureus, comparing to animals colonized by microbiota but not infected by pathogen. |
DeSeq2 (v. 1.42.0), Wald analyses testing against a null hypothesis of < |1.5|-fold change in gene expression between treatments (BenjaminiHochberg adjusted false detection rate of p <= 0.05. |
WBPaper00067479:Microbiota-Pathogen_vs_Microbiota_upregulated
|
|
Transcripts that showed significantly decreased expression in unc-30(ok613) animals at L4 larva stage, comparing to N2 animals. |
Genes exhibiting at least two-fold change were considered differentially expressed. |
WBPaper00061439:unc-30(ok613)_downregulated
|
|
Transcripts that showed significantly decreased expression in eat-2(ad465);atfs-1(RNAi) animals comparing to eat-2(ad465) animals injected with empty vector. |
fold change > 2, FDR < 0.01 |
WBPaper00067391:atfs-1(RNAi)_downregulated_eat-2(ad465)
|
|
transcripts that showed significantly decreased expression after zip-1(jy13) animals were exposed to 20 uM bortezomib for 4 hours. |
Differential expression analyses were performed using limma-voom in Galaxy. Fold change > 2, FDR < 0.05. |
WBPaper00062345:bortezomib_4h_downregulated_zip-1(jy13)
|
|
Transcripts that showed significantly increased expression in animals exposed to Camptothecin for 3 hours at 2C. |
p < 0.01, logFC > 1 or p < 0.01, logFC < -1. |
WBPaper00066610:Camptothecin_upregulated_2C_3h
|
|
Transcripts that showed significantly decreased expression in animals exposed to 400uM tamoxifen from L1 to L4 larva stage. |
DEseq2, fold change > 2 |
WBPaper00064505:tamoxifen_downregulated
|
|
Transcripts that showed significantly decreased expression in L1 neural cells comparing to in adult neural cells. |
DESeq2 (v1.18.1) fold change > 2, P-adj<0.05, using BenjaminiHochberg correction. |
WBPaper00060811:L1_vs_adult_downregulated_neural
|
|
Transcripts that showed significantly decreased expression after 24 hours of treatment by 50 uM atracurium. |
Differential expression was assessed using an empirical Bayes moderated t test within limma's linear model framework including the precision weights estimated by voom. Resulting p-values were corrected for multiple testing using the Benjamini-Hochberg false discovery rate. Fold change > 2, p-value < 0.05. |
WBPaper00061636:atracurium_downregulated
|
|
transcripts that showed significantly decreased expression after N2 animals were exposed to 20 uM bortezomib for 4 hours. |
Differential expression analyses were performed using limma-voom in Galaxy. Fold change > 2, FDR < 0.05. |
WBPaper00062345:bortezomib_4h_downregulated_N2
|